Sem categoria

After almost two centuries of blood transfusions, modern medicine faces the challenge of restricting more and more the medical transfusion practice.

PHYSICIANS and physicians treat the patient’s ANEMIA
THE PHYSICIAN of ALL PHYSICIANS treats the PATIENT who has got anemia.
The physician attention shall be the anemia’s patient, not the patient’s anemia.

Non-Transfusion Modern Medicine, basically because of two main reasons.

A The FIRST is the lack of blood and its components in Brazil and around the world. Blood is becoming a difficult therapeutic resource. Most of the blood banks around the world have reduced stocks, always below the ideal amount, even with innumerous efforts of governments and of the health professionals to stimulate blood donation. This is a real fact. The nearly possibility of no available blood for all the medical procedures has also become a more real fact. Thus, the importance of the doctor to know how to care and treat a patient with anemia without the pattern treatment of last century, by using blood transfusion.

A The SECOND reason, the main and the most worrying one, is the fact that the allogenic blood transfusions (other person’s blood) are related to several collateral effects. The transfusion blood is not different from a medicine given to a patient to treat determined health problem. As every medication therapy, transfusion therapy also has its adverse effects. National and international researches have initially demonstrated that the use of allogenic blood has an enlarged risk of transmitting some well-known types of infection, like SIDA, Hepatitis B, Hepatitis C, Chagas desease, Syphiilis, Dengue, Chikingunya Virus, Zika Virus.

In 2009, it was found that there are not only these, but there are at least 68 (sixty-eight) infection agents among virus, bacteria and protozoa which can be transmitted through blood transfusion. Besides that, recent researches showed other severe effects to the health of the patient who is submitted to blood transfusion, like heart attack, cardiac arrhythmia, stroke, lung problems, kidney failure, and multiple organs failure. These discoveries have worried the medical community.

Nevertheless, the major questioning about transfusion practice is happening now, due to several studies showing that transfused blood (allogenic) by itself has potential to cause the patient’s death. This goes against, according to these researches, all that medicine once directed about the use of blood.

DConsidering these evidences it is necessary to EVOLVE, ADVANCE. Medicine is a dynamic science and evolves according to the necessity. The challenge these days is a non-transfusion medicine, or, at least, more restrictive. Therefore the importance of disseminate alternatives and options of treatment so that the surgeon, anesthesiologist, clinic and/or the intensive care doctor, can avoid or reduce allogenic blood transfusion.

The patient tolerates anemia, the doctor cooperates with the patient in order to tolerate anemia.

The benefits of this non-transfusion medicine, better said, the benefits of implementing a program to keep the patient’s blood (Patient Blood Management – PBM) results in less time for the patient in hospital, minor risk of infections, minor risk of organs failure, and minor risk of death.

A Hospital in California (USA) did exactly this; by simply reminding the transfusion doctors the updated directions (MORE RESTRICIVE) concerning the use of allogenic blood (donated) has achieved a reduction of 24% (a quarter) the blood transfusions, and, this way, has saved US$ 1.6 million per year, and has also reduced the average time patients remained in hospital from 10.1 to 6.2 days. The main achievement of this attitude was SAVING LIVES, because the mortality rates among people who have received blood transfusions dropped from 5.5% to 3.3%.

Fonte: Revista Nature

Artigo: Poupe Sangue, Salve Vidas – PDF ~ 1,2mb

This is exactly what we would like to happen in other hospitals all around the WORLD.



2017 © Copyright - Bloodless